LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
Over the last 12 months, insiders at LENSAR, Inc. have bought $12,163 and sold $0 worth of LENSAR, Inc. stock.
On average, over the past 5 years, insiders at LENSAR, Inc. have bought $93,551 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Winer Gary M (director) — $24,326.
The last purchase of 300 shares for transaction amount of $630 was made by Winer Gary M (director) on 2023‑11‑22.
2023-11-22 | Winer Gary M | director | 300 0.0024% | $2.10 | $630 | +65.00% | ||
2023-11-16 | Winer Gary M | director | 1,000 0.0088% | $2.13 | $2,125 | +75.47% | ||
2023-11-15 | Winer Gary M | director | 500 0.0044% | $2.15 | $1,075 | +72.02% | ||
2023-11-10 | Winer Gary M | director | 1,000 0.0083% | $2.13 | $2,135 | +63.38% | ||
2023-08-11 | Winer Gary M | director | 705 0.0063% | $3.60 | $2,538 | -6.11% | ||
2023-08-10 | Winer Gary M | director | 1,000 0.0089% | $3.66 | $3,660 | -8.40% | ||
2023-05-22 | WEISNER AIMEE S | director | 16,647 0.1515% | $2.75 | $45,779 | +18.09% | ||
2023-05-19 | WEISNER AIMEE S | director | 22,153 0.2133% | $2.59 | $57,376 | +32.67% | ||
2023-05-18 | WEISNER AIMEE S | director | 7,700 0.071% | $2.61 | $20,097 | +25.95% | ||
2023-05-17 | WEISNER AIMEE S | director | 3,500 0.0316% | $2.29 | $8,015 | +40.08% | ||
2022-12-07 | STAAB THOMAS R II | Chief Financial Officer | 727 0.0069% | $3.16 | $2,294 | -7.68% | ||
2022-12-06 | STAAB THOMAS R II | Chief Financial Officer | 2,025 0.0192% | $3.16 | $6,403 | -8.34% | ||
2022-11-23 | Winer Gary M | director | 976 0.0096% | $3.60 | $3,514 | -14.49% | ||
2022-11-22 | Winer Gary M | director | 1,524 0.0147% | $3.60 | $5,486 | -16.39% | ||
2022-11-17 | Winer Gary M | director | 1,500 0.0145% | $4.10 | $6,150 | -26.34% | ||
2022-11-16 | Winer Gary M | director | 1,000 0.0097% | $4.25 | $4,250 | -28.32% | ||
2022-08-17 | Winer Gary M | 2,000 0.0194% | $6.00 | $12,000 | -46.19% | |||
2020-09-29 | PDL BIOPHARMA, INC. | 10 percent owner | 8,703 0.2335% | $11.16 | $97,125 |
Winer Gary M | director | 53345 0.4742% | $4.39 | 11 | 0 | <0.0001% |
PDL BIOPHARMA, INC. | 10 percent owner | 8667397 77.0538% | $4.39 | 1 | 0 | |
STAAB THOMAS R II | Chief Financial Officer | 135131 1.2013% | $4.39 | 2 | 0 | <0.0001% |
WEISNER AIMEE S | director | 54285 0.4826% | $4.39 | 4 | 0 | +29.2% |
Park West Asset Management Llc | $3.69M | 9.54 | 1.09M | -2.56% | -$97,045.50 | 0.28 | |
Dimensional Fund Advisors | $2.34M | 5.77 | 657,864 | -0.43% | -$10,003.90 | <0.01 | |
The Vanguard Group | $1.47M | 3.8 | 433,474 | 0% | +$0 | <0.0001 | |
Brandes Investment Partners | $1.17M | 2.9 | 330,948 | +46% | +$370,165.47 | 0.02 | |
Renaissance Technologies | $1.11M | 2.88 | 328,345 | +4.42% | +$47,225.65 | <0.01 | |
Dcf Advisers Llc | $809,281.00 | 2.09 | 238,234 | -0.96% | -$7,813.10 | 0.5 | |
Clearline Capital LP | $587,695.00 | 1.52 | 173,004 | 0% | +$0 | 0.06 | |
BlackRock | $504,357.00 | 1.3 | 148,471 | -5.4% | -$28,806.62 | <0.0001 | |
Geode Capital Management | $322,109.00 | 0.8 | 90,711 | +1.71% | +$5,425.83 | <0.0001 | |
RBF Capital, LLC | $170,101.00 | 0.44 | 50,074 | 0% | +$0 | 0.01 | |
Synovus | $146,275.00 | 0.38 | 43,060 | 0% | +$0 | <0.01 | |
State Street | $113,824.00 | 0.28 | 32,063 | -6.69% | -$8,165.02 | <0.0001 | |
Northern Trust | $95,058.00 | 0.25 | 27,983 | -16.06% | -$18,190.89 | <0.0001 | |
Bank of America | $94,456.00 | 0.24 | 27,806 | +14.38% | +$11,872.39 | <0.0001 | |
TWO SIGMA SECURITIES LLC | $60,833.00 | 0.16 | 17,908 | New | +$60,833.00 | <0.01 | |
Nuveen | $63,421.00 | 0.16 | 17,865 | 0% | +$0 | <0.0001 | |
Charles Schwab | $42,053.00 | 0.1 | 11,846 | 0% | +$0 | <0.0001 | |
Citadel Advisors LLC | $29,554.00 | 0.07 | 8,325 | -17.48% | -$6,258.70 | <0.0001 | |
UBS | $11,472.00 | 0.03 | 3,377 | +255.1% | +$8,241.36 | <0.0001 | |
Tower Research Capital | $9,760.00 | 0.03 | 2,873 | +95.44% | +$4,766.20 | <0.0001 | |
National Bank Of Canada Fi | $2,517.00 | 0.01 | 682 | New | +$2,517.00 | <0.0001 | |
Morgan Stanley | $2,456.00 | 0.01 | 723 | -50.38% | -$2,493.37 | <0.0001 | |
Comerica | $1,943.00 | 0.01 | 572 | 0% | +$0 | <0.0001 | |
RhumbLine Advisers | $1,906.00 | 0.01 | 537 | 0% | +$0 | <0.0001 | |
FIRST TENNESSEE BROKERAGE, INC. | $1,535.00 | <0.01 | 452 | New | +$1,535.00 | <0.0001 | |
Advisor Group Holdings Inc | $1,065.00 | <0.01 | 314 | -84.46% | -$5,789.67 | <0.0001 | |
Simplex Trading Llc | $0 | <0.01 | 202 | New | +$0 | <0.0001 | |
Wells Fargo | $888.00 | <0.01 | 261 | -56.43% | -$1,149.98 | <0.0001 | |
JPMorgan Chase | $909.00 | <0.01 | 256 | +2.81% | +$24.86 | <0.0001 | |
Qube Research & Technologies | $951.00 | <0.01 | 268 | 0% | +$0 | <0.0001 | |
A. MONTAG & ASSOCIATES, INC. | $255.00 | <0.01 | 75 | 0% | +$0 | <0.0001 | |
Huntington National Bank | $3.00 | <0.01 | 1 | 0% | +$0 | <0.0001 | |
Psi Advisors Llc | $51.00 | <0.01 | 15 | 0% | +$0 | <0.0001 | |
GRP Financial | $3.00 | <0.01 | 1 | 0% | +$0 | <0.0001 | |
Whittier Trust Co Of Nevada Inc | $20.00 | <0.01 | 6 | 0% | +$0 | <0.0001 | |
Royal Bank of Canada | $0 | <0.01 | 2 | -91.67% | -$0 | <0.0001 |